Week In Review: 3 More China Biopharmas Planning Hong Kong IPOs – Seeking Alpha

Week In Review: 3 More China Biopharmas Planning Hong Kong IPOs
Seeking Alpha
Mabpharm Limited, a Taizhou biotech, will IPO in Hong Kong, the eleventh pre-revenue China biopharma to be approved to list there. Mabpharm is developing a portfolio of nine biosimilars, which it hopes will prove to be biobetters. Three of the

…read more

Source:: Hong Kong News By Google News

Leave a Comment